Free Trial

Cronos Group (NASDAQ:CRON) Reaches New 52-Week Low - Time to Sell?

Cronos Group logo with Medical background

Cronos Group Inc. (NASDAQ:CRON - Get Free Report) reached a new 52-week low on Friday . The company traded as low as $1.86 and last traded at $1.88, with a volume of 67250 shares. The stock had previously closed at $1.87.

Cronos Group Stock Up 4.3 %

The business has a 50-day simple moving average of $2.08 and a 200-day simple moving average of $2.22. The company has a market cap of $745.48 million, a PE ratio of -15.00 and a beta of 0.99.

Institutional Investors Weigh In On Cronos Group

A number of institutional investors have recently added to or reduced their stakes in CRON. Mackenzie Financial Corp acquired a new position in Cronos Group during the second quarter worth $3,237,000. Tidal Investments LLC increased its stake in shares of Cronos Group by 4.4% during the third quarter. Tidal Investments LLC now owns 5,026,489 shares of the company's stock worth $11,008,000 after purchasing an additional 210,263 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Cronos Group by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,631,783 shares of the company's stock worth $6,132,000 after purchasing an additional 192,469 shares during the last quarter. Intact Investment Management Inc. lifted its stake in Cronos Group by 89.1% in the 3rd quarter. Intact Investment Management Inc. now owns 377,890 shares of the company's stock valued at $836,000 after buying an additional 178,100 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in Cronos Group by 37.9% in the 2nd quarter. Renaissance Technologies LLC now owns 464,949 shares of the company's stock worth $1,083,000 after buying an additional 127,753 shares during the last quarter. Institutional investors and hedge funds own 8.71% of the company's stock.

Cronos Group Company Profile

(Get Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Recommended Stories

Should you invest $1,000 in Cronos Group right now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines